The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritisH M Albers, R. ten Cate, Willem Verduijn et al.|Annals of the Rheumatic Diseases|2008Cited by 55
Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritisH M Albers, MW Schilham, Fina Kurreeman et al.|Arthritis & Rheumatism|2009Cited by 52
When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritisFrançois Prince, Lisette W. A. van Suijlekom‐Smit, Marinka Twilt et al.|Annals of the Rheumatic Diseases|2009Cited by 42
Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?Janneke Anink, Lisette W. A. van Suijlekom‐Smit, M.H. Otten et al.|Lara D. Veeken|2013Cited by 40